Nobel Prize goes to discoverers of checkpoint targets

Discoveries that led to a pair of first-in-world approvals for two blockbuster cancer drugs from Bristol-Myers Squibb Co. (NYSE:BMY) and touched off a new era in treating cancer were the focus of this year's Nobel Prize for Medicine.

James Allison and Tasuku Honjo were jointly awarded the prize for their respective discoveries of cancer checkpoint targets CTLA-4 and PD-1...